Merck (TICKER: MRK) Benchmark And Performance Data

there are 10 of samples in the benchmark for Merck in year 2022 in 2022. The total inventory for Merck was $6,535,000,000.00 in 2012. The total inventory for Merck was $6,226,000,000.00 in 2013. The total inventory for Merck was $5,978,000,000.00 in 2019. The total inventory for Merck was $5,953,000,000.00 in 2021. The total inventory for Merck was $5,571,000,000.00 in 2014. The total inventory for Merck was $5,554,000,000.00 in 2020. The total inventory for Merck was $5,440,000,000.00 in 2018. The total inventory for Merck was $5,096,000,000.00 in 2017. The total inventory for Merck was $4,866,000,000.00 in 2016. The total inventory for Merck was $4,700,000,000.00 in 2015. The sales, general, and administrative (SGA) for Merck was $9,634,000,000.00 in 2021. The sales, general, and administrative (SGA) for Merck was $9,455,000,000.00 in 2019. The sales, general, and administrative (SGA) for Merck was $8,955,000,000.00 in 2020. The sales, general, and administrative (SGA) for Merck was $12,776,000,000.00 in 2012. The sales, general, and administrative (SGA) for Merck was $11,911,000,000.00 in 2013. The sales, general, and administrative (SGA) for Merck was $11,606,000,000.00 in 2014. The sales, general, and administrative (SGA) for Merck was $10,313,000,000.00 in 2015. The sales, general, and administrative (SGA) for Merck was $10,102,000,000.00 in 2018. The sales, general, and administrative (SGA) for Merck was $10,074,000,000.00 in 2017. The sales, general, and administrative (SGA) for Merck was $10,017,000,000.00 in 2016. The sales, general, and administrative (SGA) for Merck was $$10,042,000,000 in 2022. The revenue volatility for Merck was 15.76% in 2022. The market capitalization for Merck was $293,024,307,175.00 in 2020. The market capitalization for Merck was $281,302,183,315.00 in 2018. The market capitalization for Merck was $269,959,551,473.00 in 2019. The market capitalization for Merck was $261,237,804,348.00 in 2021. The market capitalization for Merck was $230,952,705,921.00 in 2016. The market capitalization for Merck was $218,176,961,321.00 in 2017. The market capitalization for Merck was $207,453,275,168.00 in 2015. The market capitalization for Merck was $196,972,152,203.00 in 2012. The market capitalization for Merck was $193,715,608,803.00 in 2014. The market capitalization for Merck was $189,677,038,546.00 in 2013. The market capitalization for Merck was $$320,326,000,000 in 2022. The gross revenue for Merck was $48,704,000,000.00 in 2021. The gross revenue for Merck was $47,267,000,000.00 in 2012. The gross revenue for Merck was $44,033,000,000.00 in 2013. The gross revenue for Merck was $42,294,000,000.00 in 2018. The gross revenue for Merck was $42,237,000,000.00 in 2014. The gross revenue for Merck was $41,518,000,000.00 in 2020. The gross revenue for Merck was $40,122,000,000.00 in 2017. The gross revenue for Merck was $39,807,000,000.00 in 2016. The gross revenue for Merck was $39,498,000,000.00 in 2015. The gross revenue for Merck was $39,121,000,000.00 in 2019. The gross revenue for Merck was $$59,283,000,000 in 2022. The gross margin for Merck was $30.84% in 2022. The days sales outstanding for Merck was 58 days in 2022. The days payable outstanding for Merck was 93 days in 2022. The days of inventory for Merck was $124 in 2022. The cost of goods sold (COGS) for Merck was 29.37% in 2022. The cost of goods sold (COGS) for Merck was $16,954,000,000.00 in 2013. The cost of goods sold (COGS) for Merck was $16,768,000,000.00 in 2014. The cost of goods sold (COGS) for Merck was $16,446,000,000.00 in 2012. The cost of goods sold (COGS) for Merck was $14,934,000,000.00 in 2015. The cost of goods sold (COGS) for Merck was $14,030,000,000.00 in 2016. The cost of goods sold (COGS) for Merck was $13,626,000,000.00 in 2021. The cost of goods sold (COGS) for Merck was $13,618,000,000.00 in 2020. The cost of goods sold (COGS) for Merck was $13,509,000,000.00 in 2018. The cost of goods sold (COGS) for Merck was $12,912,000,000.00 in 2017. The cost of goods sold (COGS) for Merck was $12,016,000,000.00 in 2019. The cost of goods sold (COGS) for Merck was $$17,411,000,000 in 2022. The cash to cash cycle time for Merck was 89 in 2022. The annual percentage growth rate of Merck was -0.22% in 2022. Merck in its benchmark peer group, had rank 9 for sales growth in 2022. Merck in its benchmark peer group, had rank 6 for cost of goods sold as a percent of revenue in 2022. Merck in its benchmark peer group, had rank 6 for cash to cash cycle time in 2022. Merck in its benchmark peer group, had rank 5 days for days of inventory in 2022. Merck in its benchmark peer group, had rank 3 for gross revenue in 2022. Merck in its benchmark peer group, had rank 2 days for days sales outstanding in 2022. Merck headquarters region is West. Merck has ticker symbol MRK. Merck has the following profile: Merck & Co. , Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.. Merck has primary indstury Drug Manufacturers - General. Merck had a $$36,199,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Merck had Organon, and Eli Lilly, and AbbVie, and Pfizer, and Bristol-Myers Squibb, and Amgen, and Gilead Sciences, and Biogen, and Johnson & Johnson, and Merck benchmark peer companies for its SIC code in 2022. Merck had 69,000 number of employees in 2022. Merck had 6 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Merck had 24 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Merck had 2.75% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Merck had 2.52% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Merck had 2 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Merck had 1.41% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Merck had 0.21% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Merck can reduce overall cost by $$27,896,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Merck can reduce inventory with practices including SKU Reduction in 2022. Merck can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Merck can reduce inventory with practices including Forecast Accuracy in 2022. Merck can reduce inventory with practices including Demand Shaping in 2022. Merck can reduce days sales outstanding with practices including in 2022. Merck can increase sales revenue by $$36,199,000,000 improving sales performance to next benchmark tier in 2022. Merck can increase revenue growth by $$123,000,000 by improving growth performance to next benchmark tier in 2022. Merck can increase overall revenue by $$36,321,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Merck can increase days payables outstanding with practices including Strategic Sourcing in 2022. Merck can increase days payables outstanding by $1,413,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. Merck can improve total financial performance by $$69,886,000,000 by improving revenue, costs, and working capital in 2022. Merck can decrease overall working capital by $$5,668,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Merck can decrease inventory days by $3,979,000,000 days by reducing inventory days to next benchmark tier in 2022. Merck can decrease days sales outstanding by $276,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Merck can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Merck can accelerate revenue growth practices including Pricing Optimization in 2022. Merck can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 82 days was the measured parity or middle performance level for cash to cash cycle time in Merck's peer group in 2022. 79 days was the measured superior or top ten performance level for days of inventory in Merck's peer group in 2022. 68 days was the measured advantage or top third performance level for cash to cash cycle time in Merck's peer group in 2022. 66 days was the measured parity or middle performance level for days sales outstanding in Merck's peer group in 2022. 61 days was the measured advantage or top third performance level for days sales outstanding in Merck's peer group in 2022. 6.73% was the measured superior or top ten performance level for sales volatility in Merck's peer group in 2022. 56 days was the measured superior or top ten performance level for days sales outstanding in Merck's peer group in 2022. 37.46% was the measured superior or top ten performance level for gross margin in Merck's peer group in 2022. 37 days was the measured superior or top ten performance level for cash to cash cycle time in Merck's peer group in 2022. 26.85% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Merck's peer group in 2022. 22.98% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Merck's peer group in 2022. 21.84% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Merck's peer group in 2022. 14.35% was the measured parity or middle performance level for sales volatility in Merck's peer group in 2022. 129 days was the measured parity or middle performance level for days of inventory in Merck's peer group in 2022. 100 days was the measured advantage or top third performance level for days of inventory in Merck's peer group in 2022. 10.93% was the measured advantage or top third performance level for sales volatility in Merck's peer group in 2022. 0.03% was the measured superior or top ten performance level for sales growth in Merck's peer group in 2022. 0.00% was the measured advantage or top third performance level for sales growth in Merck's peer group in 2022. -0.01% was the measured parity or middle performance level for sales growth in Merck's peer group in 2022. $33.59% was the measured advantage or top third performance level for gross margin in Merck's peer group in 2022. $30.58% was the measured parity or middle performance level for gross margin in Merck's peer group in 2022. $$95,482,000,000 was the measured superior or top ten performance level for gross revenue in Merck's peer group in 2022. $$58,423,000,000 was the measured advantage or top third performance level for gross revenue in Merck's peer group. $$37,350,000,000 was the measured parity or middle performance level for gross revenue in Merck's peer group in 2022.